LevosulpirideThird Party Manufacturing in India

Levosulpiride is a substituted benzamide derivative that exerts its pharmacological effects primarily through selective dopamine D2 receptor antagonism. At lower doses (25-50 mg), levosulpiride acts predominantly in the gastrointestinal tract as a prokinetic agent. It blocks presynaptic D2 receptors in the enteric nervous system, which increases the release of acetylcholine from cholinergic nerve terminals in the myenteric plexus. This enhanced cholinergic activity stimulates gastric motility, promotes gastric emptying, improves lower esophageal sphincter tone, and coordinates duodenal and jejunal peristalsis. At higher doses (100 mg and above), levosulpiride crosses the blood-brain barrier and acts as an atypical antipsychotic by blocking postsynaptic D2 receptors in the mesolimbic and mesocortical dopamine pathways. Unlike typical antipsychotics, levosulpiride demonstrates relative selectivity for D2 receptors and has limited affinity for D1, adrenergic, histaminergic, and cholinergic receptors, resulting in a favorable extrapyramidal side effect profile. The R-enantiomer of sulpiride, levosulpiride is approximately twice as potent as the racemic mixture.

Levosulpiride third party manufacturing in India serves a dual therapeutic role in both gastroenterology and psychiatry, making it a versatile product for pharmaceutical portfolios. This molecule is available in multiple strengths to accommodate dose-dependent therapeutic indications.

Therapeutic Uses

Levosulpiride is prescribed for the treatment of:

• Functional Dyspepsia: Improves gastric emptying and alleviates symptoms of postprandial fullness, early satiety, and epigastric pain.
• Gastroesophageal Reflux Disease (GERD): Enhances lower esophageal sphincter pressure and accelerates esophageal acid clearance.
• Gastroparesis: Promotes gastric motility in diabetic and idiopathic gastroparesis, reducing nausea, vomiting, and abdominal discomfort.
• Irritable Bowel Syndrome (IBS): Modulates gut motility and visceral hypersensitivity in constipation-predominant IBS.
• Psychiatric Disorders (Higher Doses): Used as an atypical antipsychotic for negative and depressive symptoms of schizophrenia and as an adjunct in major depressive disorder.
• Nausea and Vomiting: Central and peripheral antiemetic effects through dopamine receptor blockade in the chemoreceptor trigger zone.

Why Choose a Levosulpiride Manufacturer in India

Levosulpiride offers the unique advantage of bridging gastroenterology and psychiatry with a single active pharmaceutical ingredient. Its availability in 25 mg, 50 mg, and 100 mg strengths allows brands to address multiple therapeutic segments from a single manufacturing partnership. Indian WHO-GMP certified manufacturers provide high-quality levosulpiride tablets at competitive pricing, making it an attractive molecule for both domestic chronic care programs and export markets in Europe, Asia, and Latin America. The well-characterized safety profile and established regulatory acceptance simplify international registration and market entry.